NM_000179.3:c.457G>T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_000179.3(MSH6):c.457G>T(p.Gly153Cys) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000179.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.G153C variant (also known as c.457G>T), located in coding exon 2 of the MSH6 gene, results from a G to T substitution at nucleotide position 457. The amino acid change results in glycine to cysteine at codon 153, an amino acid with highly dissimilar properties. However, this change occurs in the last base pair of coding exon 2, which makes it likely to have some effect on normal mRNA splicing. Using a Bayesian analysis that incorporates tumor mutation data, this variant was classified as uncertain significance by one study (Shirts BH et al. Am J Hum Genet, 2018 07;103:19-29). Another alteration impacting the same donor site (p.G153S) has been detected in a patient with rectal cancer at age 56 that showed high microsatellite instability (MSI-H) and loss of MSH6 protein staining on IHC. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. In addition, as a missense substitution the in silico analysis for this alteration is inconclusive. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Lynch syndrome Uncertain:1
MSH6 NM_000179.2:c.457G>T has a 93.3% probability of pathogenicity based on combining prior probability from public data with a likelihood ratio of 1.56 to 1, generated from evidence of seeing this as a somatic mutation in a tumor without loss of heterozygosity at the MSH6 locus. See Shirts et al 2018, PMID 29887214. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at